10.51
Schlusskurs vom Vortag:
$10.21
Offen:
$10.26
24-Stunden-Volumen:
83,365
Relative Volume:
0.25
Marktkapitalisierung:
$97.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.42M
KGV:
-1.8764
EPS:
-5.6013
Netto-Cashflow:
$-7.45M
1W Leistung:
+9.25%
1M Leistung:
+4.58%
6M Leistung:
+386.57%
1J Leistung:
-29.13%
Cervomed Inc Stock (CRVO) Company Profile
Firmenname
Cervomed Inc
Sektor
Branche
Telefon
(617) 744-4400
Adresse
20 PARK PLAZA, BOSTON
Vergleichen Sie CRVO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CRVO
Cervomed Inc
|
10.51 | 88.85M | 0 | -6.42M | -7.45M | -5.6013 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-13 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
2024-12-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-12-11 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
2024-12-11 | Herabstufung | Morgan Stanley | Overweight → Underweight |
2024-12-10 | Herabstufung | D. Boral Capital | Buy → Hold |
2024-12-06 | Eingeleitet | ROTH MKM | Buy |
2024-12-05 | Eingeleitet | H.C. Wainwright | Buy |
2024-09-18 | Eingeleitet | Chardan Capital Markets | Buy |
2024-07-26 | Eingeleitet | Morgan Stanley | Overweight |
2024-02-15 | Eingeleitet | Canaccord Genuity | Buy |
2020-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2018-03-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cervomed Inc Aktie (CRVO) Neueste Nachrichten
Sector ETF performance correlation with CervoMed Inc.CEO Change & Safe Capital Investment Plans - Newser
Chart based analysis of CervoMed Inc. trendsEarnings Recap Summary & Consistent Return Investment Signals - Newser
CervoMed Inc.’s volatility index tracking explainedPortfolio Value Summary & Long-Term Growth Plans - Newser
What are the risks of holding CervoMed Inc.July 2025 Analyst Calls & Safe Entry Trade Signal Reports - خودرو بانک
Will a bounce in CervoMed Inc. offer an exitTrade Signal Summary & Technical Pattern Alert System - Newser
CervoMed Inc. stock prediction for this weekJuly 2025 Volume & Smart Allocation Stock Reports - Newser
How high can CervoMed Inc. stock goTrade Signal Summary & Free Fast Gain Swing Trade Alerts - Newser
Regression analysis insights on CervoMed Inc. performanceGold Moves & Safe Capital Allocation Plans - Newser
What to expect from CervoMed Inc. in the next 30 days2025 Earnings Impact & Technical Pattern Recognition Alerts - Newser
Is CervoMed Inc. stock bottoming out2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
CervoMed Inc. stock trend forecast2025 Investor Takeaways & Safe Entry Momentum Tips - Newser
Can CervoMed Inc. hit a new high this month2025 Market WrapUp & Daily Price Action Insights - Newser
Measuring CervoMed Inc.’s beta against major indicesJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Will CervoMed Inc. benefit from current market trends2025 Analyst Calls & Advanced Technical Signal Analysis - خودرو بانک
Visualizing CervoMed Inc. stock with heatmapsWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
How to manage a losing position in CervoMed Inc.Weekly Market Outlook & Weekly High Return Stock Forecasts - Newser
What’s the outlook for CervoMed Inc.’s sector2025 Sector Review & Breakout Confirmation Alerts - خودرو بانک
Can CervoMed Inc. lead its sector in growthMarket Activity Report & Verified Stock Trade Ideas - خودرو بانک
When is the best time to exit CervoMed Inc.2025 Risk Factors & Accurate Intraday Trade Tips - Newser
Will CervoMed Inc. rebound enough to break evenEntry Point & Safe Entry Momentum Tips - Newser
How institutional ownership impacts CervoMed Inc. stockM&A Rumor & Long-Term Safe Investment Ideas - Newser
Smart tools for monitoring CervoMed Inc.’s price actionShare Buyback & Growth Focused Stock Pick Reports - Newser
What indicators show strength in CervoMed Inc.Trade Performance Summary & Weekly Watchlist of Top Performers - Newser
Risk adjusted return profile for CervoMed Inc. analyzed2025 Market WrapUp & Safe Entry Zone Tips - Newser
How does CervoMed Inc. compare to its peersWeekly Profit Summary & Free Community Consensus Stock Picks - خودرو بانک
Using economic indicators to assess CervoMed Inc. potentialJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
CervoMed Inc. to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
Is this a good reentry point in CervoMed Inc.Market Performance Report & Stock Portfolio Risk Control - Newser
CervoMed to Participate in Upcoming Investor Conferences - GlobeNewswire
Guidance Update: Can CervoMed Inc. navigate macro headwinds2025 Trading Volume Trends & Expert Approved Momentum Ideas - خودرو بانک
Why CervoMed Inc. is moving todayQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Is CervoMed Inc. stock a good pick for beginnersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - خودرو بانک
Earnings visualization tools for CervoMed Inc.Market Trend Review & Advanced Swing Trade Entry Alerts - Newser
Is CervoMed Inc. showing signs of accumulationMarket Trend Review & Growth Focused Stock Reports - Newser
EPS Watch: Will CervoMed Inc. benefit from government policyJuly 2025 Movers & Weekly Momentum Stock Picks - خودرو بانک
CervoMed's 15min chart shows KDJ Death Cross, bearish Marubozu formation detected. - AInvest
MACD Signals Flash Warning for CervoMed Inc. Stock getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Cervomed Inc-Aktie (CRVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):